Health
Metformin use reduces risk of death for patients with COVID-19 and diabetes, study finds – Science Daily
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.”This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
-
Noosa News24 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General24 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
General17 hours agoChinese spies, ports and Donald | Scam of the Week
-
Noosa News4 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots